Quarterly report [Sections 13 or 15(d)]

Condensed Statements of Operations (Unaudited)

v3.26.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenues
Operating Expenses:        
Research and development 1,710,000 634,000 3,178,000 2,096,000
Selling, general and administrative 1,797,000 2,748,000 7,689,000 4,731,000
Loss from Operations (3,507,000) (3,382,000) (10,867,000) (6,827,000)
Other Income (Expense)        
Interest income 39,000 36,000 164,000 106,000
Interest expense (63,000) (190,000)
Loss on initial recognition of Greenshoe Rights liability (28,736,000)
Change in fair value of Greenshoe Rights liability 11,413,000 11,413,000
Change in fair value of warrant liability 232,000 11,000 244,000
Gain on settlement of vendor payable 998,000
Other income 156,000
Total Other Income (Expense), net (24,000) 11,681,000 (15,000) (15,819,000)
Net Income (Loss) (3,531,000) 8,299,000 (10,882,000) (22,646,000)
Dividend on preferred stock (52,000) (144,000) (229,000) (229,000)
Deemed dividend (4,058,000) (433,000) (4,058,000)
Net Income (Loss) attributable to common stockholders $ (3,583,000) $ 4,097,000 $ (11,544,000) $ (26,933,000)
Net Income (Loss) Per Share - Basic $ (1.98) $ 25.99 $ (7.61) $ (222.58)
Net Income (Loss) Per Share - Diluted $ (1.98) $ 25.99 $ (7.61) $ (222.58)
Weighted average common shares outstanding - basic 1,813,759 157,629 1,517,061 121,001
Weighted average common shares outstanding - diluted 1,813,759 157,629 1,517,061 121,001